SOLUTION PROVIDED
SUPPLIER IDENTITY
General description
DIAsource ImmunoAssays, an international diagnostics company (Belgium), develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. Core products are RIA and ELISA technology and reagents for open ELISA automated analyzers as well as antibodies for use in in-vitro diagnostic assays with specific development and manufacturing programs for Vitamin D, Renin, Calcitonin and many others. We also provide selected ELISA instrumentation.
Type of Supplier
Biotechnology R&D Company - Diagnostics / Devices and Diagnostics Services
Sector of activity
Region
- Bone, Joint and Cartilage
- Diagnostics / Devices and Services
- Endocrinology / diabetology
- In vitro Diagnostics
- Medical Devices
Region of Wallonia, BE
Regional access broker
ACTIVITY DESCRIPTION
- Annick Pierrard, Interface Enterprises-University of Liège
The 3 top equipments available
- Complete dispensing and lyophilization production unit with capacities up to 35.000 vials in one batch.
- Moduline and Oysterbay equipments for the coating of microplates.
- Development, production and purification of monoclonal antibodies via the technology of hybridomas.
Know-how, expertise available
Acting as a CMO we offer large capacities in cell culture, antibodies production and purification, buffers production, dispensing in various vials (500µL - 2L), lyophilization (up to 35000 vials of 3mL per run), tubes and microplates coating, and packaging.
Recently, we added a CRO activity related to the custom synthesis of complex organic molecules, the chemical customization of commercial organic molecules and their conjugation to proteins. Our motto is connecting chemistry to biology as we have the chance to gather both expertise and facilities. We believe this combination is unique and hardly found in other companies on the market.
Possibilities of partnership
- Custom manufacturing
- OEM in and out partnerships
- National and EU funded research programs
Quality labels and accreditations
ISO 9001
ISO 13485
FDA 510k approval pending
The complex molecuse in the highlighted paragraph
Could this be referring to M+G?
RB
- Forums
- ASX - By Stock
- ADO
- Complex Organic Molecules
Complex Organic Molecules
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.001(4.55%) |
Mkt cap ! $56.77M |
Open | High | Low | Value | Volume |
2.2¢ | 2.4¢ | 2.2¢ | $54.24K | 2.388M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 301926 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 124809 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 301749 | 0.023 |
3 | 340301 | 0.022 |
8 | 1458170 | 0.021 |
12 | 1946809 | 0.020 |
8 | 1129867 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 124809 | 2 |
0.025 | 240865 | 5 |
0.028 | 190000 | 1 |
0.029 | 34000 | 3 |
0.030 | 350000 | 1 |
Last trade - 15.24pm 02/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |